Bristol-Myers Squibb (BMY)
61.12
1.10 (1.83%)
At close: Mar 31, 2025, 3:59 PM
60.87
-0.40%
After-hours: Mar 31, 2025, 07:46 PM EDT
Inrebic Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 27M | 2M | +8.00% |
| Mar 31, 2023 | 25M | 2M | +8.70% |
| Dec 31, 2022 | 23M | 2M | +9.52% |
| Sep 30, 2022 | 21M | -2M | -8.70% |
| Jun 30, 2022 | 23M | n/a | n/a |
| Mar 31, 2022 | 23M | -2M | -8.00% |
| Dec 31, 2021 | 25M | 4M | +19.05% |
| Sep 30, 2021 | 21M | 9M | +75.00% |
| Jun 30, 2021 | 12M | -746M | -98.42% |
| Mar 31, 2021 | 758M | -109M | -12.57% |
| Dec 31, 2020 | 867M | 41M | +4.96% |
| Sep 30, 2020 | 826M | 81M | +10.87% |
| Jun 30, 2020 | 745M | 32M | +4.49% |
| Mar 31, 2020 | 713M | n/a | n/a |
| Dec 31, 2019 | n/a | n/a | n/a |
| Sep 30, 2019 | n/a | n/a | n/a |
| Jun 30, 2019 | n/a | n/a | n/a |
| Mar 31, 2019 | n/a | n/a | n/a |
| Dec 31, 2018 | n/a | n/a | n/a |
| Sep 30, 2018 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |
| Dec 31, 2017 | n/a | n/a | n/a |
| Sep 30, 2017 | n/a | n/a | n/a |
| Jun 30, 2017 | n/a | n/a | n/a |
| Mar 31, 2017 | n/a | n/a | n/a |
| Dec 31, 2016 | n/a | n/a | n/a |
| Sep 30, 2016 | n/a | n/a | n/a |
| Jun 30, 2016 | n/a | n/a | n/a |
| Mar 31, 2016 | n/a | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Sep 30, 2015 | n/a | n/a | n/a |
| Jun 30, 2015 | n/a | n/a | n/a |
| Mar 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Sep 30, 2014 | n/a | n/a | n/a |
| Jun 30, 2014 | n/a | n/a | n/a |
| Mar 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Sep 30, 2013 | n/a | n/a | n/a |
| Jun 30, 2013 | n/a | n/a | n/a |